Neutralizing antibody response after immunization with a COVID-19 bivalent vaccine: insights to the future (2024)
- Authors:
- Souza, Milena Silva
- Farias, Jéssica Pires
- Santos, Robert Andreata
- Silva, Marianne Pereira
- Brito, Ruth Dálety da Silva
- Silva, Marcia Duarte Barbosa da
- Peter, Cristina Mendes
- Cirilo, Marcus Vinicius de França
- Luiz, Wilson Barros
- Birbrair, Alexander
- Vidal, Paloma Oliveira
- Amarante, Maria Fernanda Castro
- Candido, Erika Donizette de Oliveira
- Munhoz, Aldilene Silva
- Malta, Fernanda de Mello
- Dorlass, Erick Gustavo
- Machado, Rafael Rahal Guaragna
- Pinho, Joao Renato Rebello
- Oliveira, Danielle Bruna Leal de
- Maricato, Juliana Terzi
- Braconi, Carla Torres
- Janini, Luiz Mário Ramos
- Amorim, Jaime Henrique
- Ferreira, Luis Carlos de Souza
- Durigon, Edison Luiz
- Souza, Milena Silva
- USP affiliated authors: FERREIRA, LUIS CARLOS DE SOUZA - ICB ; DURIGON, EDISON LUIZ - ICB ; FARIAS, JÉSSICA PIRES - ICB ; SANTOS, ROBERT ANDREATA - ICB ; AMARANTE, MARIA FERNANDA DE CASTRO - ICB ; CANDIDO, ÉRIKA DONIZETTI DE OLIVEIRA - ICB ; MACHADO, RAFAEL RAHAL GUARAGNA - ICB
- Unidade: ICB
- DOI: 10.1002/jmv.29416
- Subjects: MICROBIOLOGIA; EPITOPOS; COVID-19; VACINAS VIRAIS; GLICOPROTEÍNAS DA MEMBRANA; ANTICORPOS; VARIAÇÃO GENÉTICA
- Language: Inglês
- Imprenta:
- Publisher: John Wiley & Sons, Inc.
- Publisher place: Hoboken, NJ
- Date published: 2024
- Source:
- Título: Journal of Medical Virology
- ISSN: 1096-9071
- Volume/Número/Paginação/Ano: v. 96, n. 2, art. e29416, 9 p., 2024
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by
-
ABNT
SOUZA, Milena Silva et al. Neutralizing antibody response after immunization with a COVID-19 bivalent vaccine: insights to the future. Journal of Medical Virology, v. 96, n. 2, p. 9 , 2024Tradução . . Disponível em: https://doi.org/10.1002/jmv.29416. Acesso em: 28 dez. 2025. -
APA
Souza, M. S., Farias, J. P., Santos, R. A., Silva, M. P., Brito, R. D. da S., Silva, M. D. B. da, et al. (2024). Neutralizing antibody response after immunization with a COVID-19 bivalent vaccine: insights to the future. Journal of Medical Virology, 96( 2), 9 . doi:10.1002/jmv.29416 -
NLM
Souza MS, Farias JP, Santos RA, Silva MP, Brito RD da S, Silva MDB da, Peter CM, Cirilo MV de F, Luiz WB, Birbrair A, Vidal PO, Amarante MFC, Candido ED de O, Munhoz AS, Malta F de M, Dorlass EG, Machado RRG, Pinho JRR, Oliveira DBL de, Maricato JT, Braconi CT, Janini LMR, Amorim JH, Ferreira LC de S, Durigon EL. Neutralizing antibody response after immunization with a COVID-19 bivalent vaccine: insights to the future [Internet]. Journal of Medical Virology. 2024 ; 96( 2): 9 .[citado 2025 dez. 28 ] Available from: https://doi.org/10.1002/jmv.29416 -
Vancouver
Souza MS, Farias JP, Santos RA, Silva MP, Brito RD da S, Silva MDB da, Peter CM, Cirilo MV de F, Luiz WB, Birbrair A, Vidal PO, Amarante MFC, Candido ED de O, Munhoz AS, Malta F de M, Dorlass EG, Machado RRG, Pinho JRR, Oliveira DBL de, Maricato JT, Braconi CT, Janini LMR, Amorim JH, Ferreira LC de S, Durigon EL. Neutralizing antibody response after immunization with a COVID-19 bivalent vaccine: insights to the future [Internet]. Journal of Medical Virology. 2024 ; 96( 2): 9 .[citado 2025 dez. 28 ] Available from: https://doi.org/10.1002/jmv.29416 - Identification of Zika Virus NS1-Derived Peptides with potential applications in serological tests
- Serotype-specific dengue virus IgG assay using EDIII-based recombinant proteins and its application in an endemic population in northeast Brazil
- Declining COVID-19 vaccination coverage in Brazil: a global health warning
- Cross-lineage protection between chikv primary infection and mayv secondary exposure in mice
- Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial
- Antibody-inducing properties of a prototype bivalent herpes simplex virus/enterotoxigenic Escherichia coli DNA vaccine
- Antibody inducing properties of a prototype bivalent herpes simplex virus/enterotoxigenic Escherichia coli DNA vaccine
- Social determinants associated with Zika virus infection in pregnant women
- Dermatological manifestations in COVID-19: a case study of SARS-CoV-2 infection in a genetic thrombophilic patient with Mthfr mutation
- The third vaccine dose significantly reduces susceptibility to the B.1.1.529 (Omicron) SARS-CoV-2 variant
Informações sobre o DOI: 10.1002/jmv.29416 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
Neutralizing_antibody_res... | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
